Abstract: A method for firmware debug trace capture includes creating a hand-off block (“HOB”), capturing first debug trace statements during a boot sequence of a computer and writing the first debug trace statements to the HOB. A trace memory buffer can be created and the first debug trace statements can be copied from the HOB to the trace memory buffer. Second debug trace statements are captured during the boot sequence and appended to the trace memory buffer. In some configurations, the first debug trace statements can be written to the HOB during the pre-Extensible Firmware Interface initialization (“PEI”) phase of the boot sequence and the second debug trace statements can be written to the trace memory buffer during the driver execution (“DXE”) phase of the boot sequence.

Abstract: A firmware can include multiple features for multiple users enabled based on the presence of authenticated variables. When attempting to access functionality of a feature, the firmware will check for the presence of an authenticated variable corresponding to the feature. The authenticated variable for the feature may be installed by a user. The firmware may data to enable a feature that includes an authenticated variable for enabling the feature and an authenticated variable corresponding to an end-user of the firmware. If the firmware has access to the end-user authenticated variable, the feature authenticated variable is installed.

Abstract: A method for firmware debug trace capture includes creating a hand-off block (“HOB”), capturing first debug trace statements during a boot sequence of a computer and writing the first debug trace statements to the HOB. A trace memory buffer can be created and the first debug trace statements can be copied from the HOB to the trace memory buffer. Second debug trace statements are captured during the boot sequence and appended to the trace memory buffer. In some configurations, the first debug trace statements can be written to the HOB during the pre-Extensible Firmware Interface initialization (“PEI”) phase of the boot sequence and the second debug trace statements can be written to the trace memory buffer during the driver execution (“DXE”) phase of the boot sequence.

Abstract: A firmware can include multiple features for multiple users enabled based on the presence of authenticated variables. When attempting to access functionality of a feature, the firmware will check for the presence of an authenticated variable corresponding to the feature. The authenticated variable for the feature may be installed by a user. The firmware may data to enable a feature that includes an authenticated variable for enabling the feature and an authenticated variable corresponding to an end-user of the firmware. If the firmware has access to the end-user authenticated variable, the feature authenticated variable is installed.

Abstract: Debug trace statements from a firmware are captured during a boot cycle of a computer executing the firmware. The debug trace statements are written to a motherboard's Serial Peripheral Interface (“SPI”) device. A microcontroller's SPI device receives the debug trace statements from the motherboard's SPI device, transforms the data format of the debug trace statements, and transmits the transformed debug trace statements over a serial communications port of the microcontroller.

Abstract: A method for firmware debug trace capture includes creating a hand-off block (“HOB”), capturing first debug trace statements during a boot sequence of a computer and writing the first debug trace statements to the HOB. A trace memory buffer can be created and the first debug trace statements can be copied from the HOB to the trace memory buffer. Second debug trace statements are captured during the boot sequence and appended to the trace memory buffer. In some configurations, the first debug trace statements can be written to the HOB during the pre-Extensible Firmware Interface initialization (“PEI”) phase of the boot sequence and the second debug trace statements can be written to the trace memory buffer during the driver execution (“DXE”) phase of the boot sequence.

Abstract: A method is provided for classifying a color printer gamut into a plurality of gamut subclasses including representing the color printer gamut as a composite of gamut classes wherein each gamut class is comprised of a subset of printer color separations; and, assigning selected spot color targets to determined ones of the gamut classes. The method further includes determining if the selected spot color target is located inside, or on-boundary, or outside of the gamut classes.

Abstract: A method is provided for classifying a color printer gamut into a plurality of gamut subclasses including representing the color printer gamut as a composite of gamut classes wherein each gamut class is comprised of a subset of printer color separations; and, assigning selected spot color targets to determined ones of the gamut classes. The method further includes determining if the selected spot color target is located inside, or on-boundary, or outside of the gamut classes.

Abstract: A glucuronide metabolite of tigecycline, and its corresponding epimer, have been identified in humans treated with tigecycline. Mass spectral data have been used to identify these structures.

Abstract: This disclosure relates generally to methods and systems for color management in image/text printing or display systems, and more particularly to a system and method for automatically achieving spot color production through use of a plurality of gain matrices per spot color in determining spot color coordinates. Furthermore, this disclosure provides a means for mapping out-of-gamut target spot colors substantially near a boundary of the gamut of an image output device, such as a printer or display.

Abstract: Compounds of formula I are described herein which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. or pharmaceutically acceptable salts thereof, wherein each of R1, R2, R3, R4, Rx, Ry, and n are as defined herein. Such compounds, and compositions thereof, are useful for treating a variety of central nervous system disorders such as schizophrenia.

Abstract: A glucuronide metabolite of tigecycline, and its corresponding epimer, have been identified in humans treated with tigecycline. Mass spectral data have been used to identify these structures.